The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after ...
UK pharma major GSK today announced positive headline results from two Phase III clinical trials, ANCHOR-1 and ANCHOR-2, ...
UK pharma major AstraZeneca and Japanese drugmaker Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has won conditional approval in China as a monotherapy for the treatment of adult patients with ...